DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

ArQule, Inc. (NASDAQ: ARQL)

2.20 0.06 (2.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARQL $2.20 2.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.15
Previous Close $2.14
Daily Range $2.15 - $2.29
52-Week Range $1.04 - $2.50
Market Cap $138.2M
P/E Ratio -5.78
Dividend (Yield) $0.00 (0.0%)
Volume 249,912
Average Daily Volume 589,401
Current FY EPS -$0.32

Sector

Healthcare

Industry

Drug Makers

ArQule, Inc. (ARQL) Description

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics. Website: http://www.arqule.com/

News & Commentary

This Week in Biotech: Clinical Trials and Tribulations

The J.P. Morgan Healthcare Conference led to the release of five important clinical updates this week.

Pacira Down on Subpoena on Exparel Marketing Issues - Analyst Blog

Pacira Down on Subpoena on Exparel Marketing Issues - Analyst Blog

Pacira Pharmaceuticals (PCRX) Falls: Stock Goes Down 9.7% - Tale of the Tape

Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog

Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog

Pacira Announces Encouraging Data on Lead Drug Exparel - Analyst Blog

Pacira Announces Encouraging Data on Lead Drug Exparel - Analyst Blog

Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog

Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog

Zacks Rank #1 Additions for Thursday - Tale of the Tape

Shire Reaches Agreement with the FDA for ADHD Candidate - Analyst Blog

Zacks Rank #1 Additions for Thursday - Tale of the Tape

Receptos, Inc. (RCPT) in Focus: Stock Jumps 5.2% - Tale of the Tape

Benzinga's Top #PreMarket Gainers

See More ARQL News...

ARQL's Top Competitors

ARQL $2.20 (2.80%)
Current stock: ARQL
AMGN $165.97 (1.46%)
Current stock: AMGN
GILD $100.66 (-0.72%)
Current stock: GILD
BIIB $422.92 (0.83%)
Current stock: BIIB